Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Immuno-oncology (IO) is one of the most active area of clinical development. In the past few years, the IO clinical landscape has shifted towards combination trials which are trials that investigate IO therapies in combination with other therapies. To address this shift in the IO clinical trial landscape, Trialtrove has added three new IO combination tags to Trialtrove records that enable easy retrieval of IO combination trials. These tags capture the most common types of IO combination trials:
IO/IO Combination - clinical trials that evaluate the combination of two or more immuno-oncology drugs
IO/Targeted Combination - clinical trials that evaluate the combination of at least one immuno-oncology drug and at least one drug acting via a specific molecular target
IO/Cytotoxic Combination - clinical trials that evaluate the combination of at least one immuno-oncology drug and at least one drug acting as a broad-spectrum, cytotoxic agent
While all relevant Trialtrove records now contain the new IO tags, they are exclusively searchable using the next generation of Trialtrove. To introduce this enhancement, we compiled some key insights about IO combination trials and a visual overview of the IO competitive landscape.
Source: Trialtrove, data retrieved September 14, 2017 Authors: Maria A. Berezina, PhD and Rachel Meighan-Mantha, PhD Methodology: Combination trials included only those trials evaluating an IO drug or therapy in combination with another drug or therapy. Trials evaluating an IO drug or therapy alone or only with a non-drug intervention such as radiotherapy or surgery were categorized as Monotherapy trials. Initiation date was used for the charts with "Years".
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Support the development and validation of your strategic plans and ensure commercial decisions are based on marketplace realities. Datamonitor Healthcare offers expert coverage of key diseases, treatments, companies, drugs, market access and market trends. Our primary research with physicians, payers, and KOLs (key opinion leaders) informs our treatment standards data and patient-based forecasts.
To build and maintain gold-standard, next generation R&D intelligence tools, Sitetrove, Trialtrove, Pharmaprojects, and Trialpredict have been undergoing a major program of investment. In addition to the many new and exciting changes on the horizon, the robust and reliable Citeline tools that you use to inform your business decisions will formally join Informa’s Pharma Intelligence family of brands.
The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.
Looking for more products Product Finder
